New drug SPY003-207 tested in healthy people for first time
NCT ID NCT06873724
First seen Mar 22, 2026 · Last updated May 21, 2026 · Updated 8 times
Summary
This early-stage study tests a single dose of the experimental drug SPY003-207 in 59 healthy adults to check its safety and how the body processes it. Participants are randomly assigned to receive either the drug or a placebo, and neither they nor the researchers know who gets which. The main goal is to see if any side effects occur and to measure drug levels in the blood.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Spyre Site 1
Montreal, Quebec, H3P 3P1, Canada
-
Spyre Site 2
Cypress, California, 90630, United States
Conditions
Explore the condition pages connected to this study.